Guus P. Leijte

727 total citations
20 papers, 446 citations indexed

About

Guus P. Leijte is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Guus P. Leijte has authored 20 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Guus P. Leijte's work include Immune Response and Inflammation (9 papers), Sepsis Diagnosis and Treatment (9 papers) and Immune cells in cancer (4 papers). Guus P. Leijte is often cited by papers focused on Immune Response and Inflammation (9 papers), Sepsis Diagnosis and Treatment (9 papers) and Immune cells in cancer (4 papers). Guus P. Leijte collaborates with scholars based in Netherlands, United States and Germany. Guus P. Leijte's co-authors include Peter Pickkers, Matthijs Kox, Niklas Bruse, Christopher Geven, Dirk van Lier, Jelle Gerretsen, Remi Beunders, Fabienne Venet, Morgane Gossez and Leo Koenderman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care Medicine and Frontiers in Immunology.

In The Last Decade

Guus P. Leijte

20 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guus P. Leijte Netherlands 12 192 163 83 56 50 20 446
Laure Stiel France 9 180 0.9× 125 0.8× 79 1.0× 28 0.5× 84 1.7× 15 388
Thibaut Girardot France 7 134 0.7× 191 1.2× 68 0.8× 46 0.8× 70 1.4× 11 383
Dale Osborne United States 10 254 1.3× 236 1.4× 80 1.0× 41 0.7× 93 1.9× 14 494
Ronni R. Plovsing Denmark 15 94 0.5× 164 1.0× 78 0.9× 88 1.6× 75 1.5× 36 573
Naoki Aikawa Japan 6 226 1.2× 198 1.2× 115 1.4× 51 0.9× 45 0.9× 13 506
Ángela Cuenca United States 9 192 1.0× 179 1.1× 70 0.8× 50 0.9× 100 2.0× 10 425
Klaus Emmanuilidis Germany 9 378 2.0× 263 1.6× 111 1.3× 62 1.1× 59 1.2× 10 636
Dijoia B. Darden United States 14 109 0.6× 165 1.0× 93 1.1× 36 0.6× 117 2.3× 20 379
Naohide Kuriyama Japan 12 87 0.5× 126 0.8× 95 1.1× 54 1.0× 78 1.6× 43 420
Sabitha Eppanapally United States 4 165 0.9× 154 0.9× 226 2.7× 71 1.3× 63 1.3× 6 573

Countries citing papers authored by Guus P. Leijte

Since Specialization
Citations

This map shows the geographic impact of Guus P. Leijte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guus P. Leijte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guus P. Leijte more than expected).

Fields of papers citing papers by Guus P. Leijte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guus P. Leijte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guus P. Leijte. The network helps show where Guus P. Leijte may publish in the future.

Co-authorship network of co-authors of Guus P. Leijte

This figure shows the co-authorship network connecting the top 25 collaborators of Guus P. Leijte. A scholar is included among the top collaborators of Guus P. Leijte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guus P. Leijte. Guus P. Leijte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schrijver, Irene T., Antonios Kritikos, Guus P. Leijte, et al.. (2024). Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients. Cells. 13(4). 314–314. 2 indexed citations
3.
Leijte, Guus P., Gerben M. Franssen, Niklas Bruse, et al.. (2021). Human in vivo neuroimaging to detect reprogramming of the cerebral immune response following repeated systemic inflammation. Brain Behavior and Immunity. 95. 321–329. 9 indexed citations
4.
Hoedemaekers, Cornelia, Guus P. Leijte, Peter Pickkers, et al.. (2021). Near-Infrared Spectroscopy-Derived Dynamic Cerebral Autoregulation in Experimental Human Endotoxemia—An Exploratory Study. Frontiers in Neurology. 12. 695705–695705. 4 indexed citations
5.
Bongers, Suzanne, Erinke van Grinsven, Selma van Staveren, et al.. (2021). Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation. Frontiers in Immunology. 12. 38 indexed citations
6.
Beunders, Remi, et al.. (2020). Endotoxemia-Induced Release of Pro-inflammatory Mediators Are Associated With Increased Glomerular Filtration Rate in Humans in vivo. Frontiers in Medicine. 7. 559671–559671. 11 indexed citations
7.
Leijte, Guus P., Thomas Rimmelé, Matthijs Kox, et al.. (2020). Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes. Critical Care. 24(1). 110–110. 76 indexed citations
8.
Koeken, Valerie A. C. M., Guus P. Leijte, Vera P. Mourits, et al.. (2020). The effect of BCG vaccination on alveolar macrophages obtained from induced sputum from healthy volunteers. Cytokine. 133. 155135–155135. 12 indexed citations
9.
Leijte, Guus P., Niklas Bruse, Matthijs Kox, et al.. (2020). Differentiation and activation of eosinophils in the human bone marrow during experimental human endotoxemia. Journal of Leukocyte Biology. 108(5). 1665–1671. 25 indexed citations
10.
Beunders, Remi, et al.. (2020). Proenkephalin Compared to Conventional Methods to Assess Kidney Function in Critically Ill Sepsis Patients. Shock. 54(3). 308–314. 43 indexed citations
11.
Grondman, Inge, Rob J.W. Arts, Rebecca M. Koch, et al.. (2019). Frontline Science: Endotoxin-induced immunotolerance is associated with loss of monocyte metabolic plasticity and reduction of oxidative burst. Journal of Leukocyte Biology. 106(1). 11–25. 35 indexed citations
12.
Staveren, Selma van, Erinke van Grinsven, Marije Bartels, et al.. (2019). Characterization of the phenotype of human eosinophils and their progenitors in the bone marrow of healthy individuals. Haematologica. 105(2). e52–e56. 24 indexed citations
13.
Leijte, Guus P., Dorien Kiers, Jelle Gerretsen, et al.. (2019). Treatment With Acetylsalicylic Acid Reverses Endotoxin Tolerance in Humans In Vivo: A Randomized Placebo-Controlled Study. Critical Care Medicine. 47(4). 508–516. 22 indexed citations
14.
Kiers, Dorien, Guus P. Leijte, Jelle Gerretsen, et al.. (2019). Comparison of different lots of endotoxin and evaluation of in vivo potency over time in the experimental human endotoxemia model. Innate Immunity. 25(1). 34–45. 12 indexed citations
15.
Leijte, Guus P., et al.. (2019). Dynamic Cerebral Autoregulation and Critical Closing Pressure in Experimental Human Endotoxemia and Sepsis Patients. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Lier, Dirk van, Christopher Geven, Guus P. Leijte, & Peter Pickkers. (2018). Experimental human endotoxemia as a model of systemic inflammation. Biochimie. 159. 99–106. 63 indexed citations
19.
Bruse, Niklas, Guus P. Leijte, Peter Pickkers, & Matthijs Kox. (2018). New frontiers in precision medicine for sepsis-induced immunoparalysis. Expert Review of Clinical Immunology. 15(3). 251–263. 19 indexed citations
20.
Timmermans, Kim, Guus P. Leijte, Matthijs Kox, et al.. (2017). Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients. Acta Haematologica. 138(1). 39–43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026